Selective Blockade of Vascular Endothelial Growth Factor Receptor 2 With an Antibody Against Tumor-Derived Vascular Endothelial Growth Factor Controls the Growth of Human Pancreatic Adenocarcinoma Xenografts

By Holloway Shane   Beck Adam   Shivakumar Latha   Shih Jessica   Fleming Jason   Brekken Rolf  

Annals of Surgical Oncology, Vol. 13, Iss. 8, 2006-08 ,pp. : 1145-1155

Springer Publishing Company

Access to resources Recommend Favorite

Characterization of the expression and clinical features of epidermal growth factor receptor and vascular endothelial growth factor receptor2 in esophageal carcinoma

By            

Oncology Letters, Vol. 10, Iss. 6, 2015-01 ,pp. : 3696-3704

Spandidos Publications

Access to resources Recommend Favorite

Anti-vascular endothelial growth factor antibody single therapy for pancreatic neuroendocrine carcinoma exhibits a marked tumor growth-inhibitory effect

By Kasuya Kazuhiko   Nagakawa Yuichi   Suzuki Minako   Tanaka Hiroaki   Ohta Hiroshi   Itoi Takao   Tsuchida Akihiko  

Experimental and Therapeutic Medicine, Vol. 2, Iss. 6, 2011-11 ,pp. : 1047-1052

Spandidos Publications

Access to resources Recommend Favorite

Wnt3a upregulates prostaglandin F2α-stimulated vascular endothelial growth factor synthesis in osteoblasts

By            

Molecular Medicine Reports, Vol. 6, Iss. 2, 2012-01 ,pp. : 421-425

Spandidos Publications

Access to resources Recommend Favorite

γ-secretase inhibitor up-regulates vascular endothelial growth factor receptor-2 and endothelial nitric oxide synthase

By            

Experimental and Therapeutic Medicine, Vol. 2, Iss. 4, 2011-01 ,pp. : 725-729

Spandidos Publications

Access to resources Recommend Favorite